共 41 条
[1]
Goldstein J.L., Schrott H.G., Hazzard W.R., Bierman E.L., Motulsky A.G., Hyperlipidemia in coronary heart disease, II: Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia, J Clin Invest, 52, pp. 1544-1568, (1973)
[2]
Whayne T.F., Alaupovic P., Curry M.D., Lee E.T., Anderson P.S., Schlechter E., Plasma apolipoprotein B and VLDL, LDL and HDL-cholesterol as risk factors in the development of coronary artery disease in male patients examined by angiography, Atherosclerosis, 39, pp. 411-424, (1981)
[3]
Lusis A.J., Genetic factors affecting blood lipoproteins: The candidate gene approach, J Lipid Res, 29, pp. 397-429, (1988)
[4]
Genest Jr. J.J., Martin-Munley S.S., McNamara J.R., Ordovas J.M., Jenner J., Meyers R.H., Silberman S.R., Wilson P.W.F., Salem D.N., Schaefer E.J., Familial lipoprotein disorders in patients with premature coronary artery disease, Circulation, 85, pp. 2025-2033, (1992)
[5]
Kwiterovich P.O., Coresh J., Smith H.H., Bachorik P.S., Derby C.A., Pearson T.A., Comparison of the plasma levels of apolipoprotein B and A-I, and other risk factors in men and women with premature coronary artery disease, Am J Cardiol, 69, pp. 1015-1021, (1992)
[6]
Mahley R.W., Innerarity T.L., Rall S.C., Weisgraber K.H., Plasma lipoproteins: Apolipoprotein structure and function, J Lipid Res, 25, pp. 1277-1294, (1984)
[7]
Breslow J.L., Genetic basis of lipoprotein disorders, J Clin Invest, 84, pp. 373-380, (1989)
[8]
Brown W.V., Baginsky M.L., Inhibition of lipoprotein lipase by an apoprotein of human very low density lipoprotein, Biochem Biophys Res Commun, 46, pp. 375-382, (1972)
[9]
Wang C.-S., McConathy W.J., Kloer H.U., Alaupovic P., Modulation of lipoprotein lipase activity by apolipoproteins: Effect of apolipoprotein CIII, J Clin Invest, 75, pp. 384-390, (1985)
[10]
Ginsberg H.N., Le N.-A., Goldberg I.J., Gibson J.C., Rubinstein A., Wang-Iversen P., Norum R., Brown W.V., Apolipoprotein B metabolism in subjects with deficiency of apolipoprotein CIII and AI: Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo, J Clin Invest, 78, pp. 1287-1295, (1986)